InvestorsHub Logo
Followers 2544
Posts 250729
Boards Moderated 34
Alias Born 05/06/2014

Re: None

Monday, 09/26/2016 2:22:36 AM

Monday, September 26, 2016 2:22:36 AM

Post# of 182879
$PMCB Phase 1 - Pharmacyte Biotech Inc research using Melligen Cells

Project Member(s):
Simpson, A.
Funding or Partner Organisation:
Pharmacyte Biotech Inc
Start year:
2015

Summary:
This is a first phase engagement with Pharmacyte Biotech Inc (a US based cell therapy company formerly known as Nuvilex) around investigating the in vitro and in vivo performance of UTS technology (Melligen Cells for diabetes treatment) once encapsulated. Future phases may result in more detailed in vitro and in vivo studies investigating the encapsulated Melligen cells.

Pharmacyte, Pharmacyte Biotech, Nuvilex, Melligen, Diabetes, Simpson

Regenerative Medicine (incl. Stem Cells and Tissue Engineering), Diabetes

http://cfsites1.uts.edu.au/find/projects/detail.cfm?ProjectId=2014000473

investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.